Andrew Wolff
Overview
Explore the profile of Andrew Wolff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko J, Reginato W, Wolff A, Lobo D
Development
. 2024 Apr;
151(9).
PMID: 38619319
Adult planarians can grow when fed and degrow (shrink) when starved while maintaining their whole-body shape. It is unknown how the morphogens patterning the planarian axes are coordinated during feeding...
2.
Wolff A, Wagner C, Wolf J, Lobo D
STAR Protoc
. 2022 Jun;
3(3):101458.
PMID: 35733605
The synthesis of single-stranded riboprobes or double-stranded RNAs for hybridization and gene knockdowns often use vectors that require time-consuming plasmid restriction digests and inefficient gel purifications. Here, we present a...
3.
Wolff A, Hinman V
Genes (Basel)
. 2021 Aug;
12(7).
PMID: 34356079
The ability to regenerate is scattered among the metazoan tree of life. Further still, regenerative capacity varies widely within these specific organisms. Numerous organisms, all with different regenerative capabilities, have...
4.
Cary G, Wolff A, Zueva O, Pattinato J, Hinman V
BMC Biol
. 2019 Feb;
17(1):16.
PMID: 30795750
Background: Metazoan lineages exhibit a wide range of regenerative capabilities that vary among developmental stage and tissue type. The most robust regenerative abilities are apparent in the phyla Cnidaria, Platyhelminthes,...
5.
Meng L, Bian A, Jordan S, Wolff A, Shefner J, Andrews J
Amyotroph Lateral Scler Frontotemporal Degener
. 2017 Sep;
19(1-2):134-142.
PMID: 28891333
Objective: To determine amyotrophic lateral sclerosis (ALS)-associated costs incurred by patients covered by Medicare and/or commercial insurance before, during and after diagnosis and provide cost details. Methods: Costs were calculated...
6.
Zhang M, Tsimelzon A, Chang C, Fan C, Wolff A, Perou C, et al.
Cancer Discov
. 2015 Mar;
5(5):520-33.
PMID: 25735774
Unlabelled: Intratumoral heterogeneity correlates with clinical outcome and reflects the cellular complexity and dynamics within a tumor. Such heterogeneity is thought to contribute to radio- and chemoresistance because many treatments...
7.
OConnor O, Gerecitano J, Van Deventer H, Hainsworth J, Zullo K, Saikali K, et al.
Leuk Lymphoma
. 2015 Feb;
56(9):2585-91.
PMID: 25665464
This was a phase I study of SB-743921 (SB-921) in patients with relapsed/refractory lymphoma. Previous studies established that neutropenia was the only dose limiting toxicity (DLT). The primary objective was...
8.
Gordi T, Frohna P, Sun H, Wolff A, Belardinelli L, Lieu H
Clin Pharmacokinet
. 2006 Nov;
45(12):1201-12.
PMID: 17112296
Objectives: The aims of this study were to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of regadenoson (CVT-3146) in healthy, male volunteers. Methods: Thirty-six healthy, male volunteers aged 18-50 years...
9.
Gordon J, Wolff A, Luhmann S, Ortman M, Dobbs M, Schoenecker P
J Pediatr Orthop B
. 2005 Feb;
14(2):101-4.
PMID: 15703519
Seventy-one patients with 83 septic joints due to idiopathic septic arthritis were investigated retrospectively. Forty-three joints were closed primarily while 40 underwent delayed primary closure. Two joints in each group...
10.
Sabbah H, Chandler M, Mishima T, Suzuki G, Chaudhry P, Nass O, et al.
J Card Fail
. 2003 Jan;
8(6):416-22.
PMID: 12528095
Background: Abnormalities of energy metabolism are often cited as key elements in the progressive worsening of left ventricular (LV) dysfunction that characterizes the heart failure (HF) state. The present study...